(Therapeutic Development and Bioimaging thematic programmes of the Semmelweis University)
(RRF-2.3.1-21-2022-00003)
(ÚNKP-21-5)
Új Nemzeti Kiválóság Program(ÚNKP-21-3-I.) Támogató: Innovációs és Technológiai Minisztérium
(FK 142573) Támogató: NKFIH
We aimed to confirm that three-dimensional echocardiography (3DE)-derived right ventricular
(RV) ejection fraction (EF) is better associated with adverse cardiopulmonary outcomes
than the conventional echocardiographic parameters.We performed a meta-analysis of
studies reporting the impact of unit change of RVEF, tricuspid annular plane systolic
excursion (TAPSE), fractional area change (FAC), and free-wall longitudinal strain
(FWLS) on clinical outcomes (all-cause mortality and/or adverse cardiopulmonary outcomes).
Hazard ratios (HR) were rescaled by the within-study standard deviations (SD) to represent
standardized changes. Within each study, we calculated the ratio of HRs related to
1 SD reduction in RVEF versus TAPSE, or FAC, or FWLS, to quantify the association
of RVEF with adverse outcomes relative to the other metrics. These ratios of HRs were
pooled using random-effects models.Ten independent studies were identified as suitable,
including data on 1,928 patients with various cardiopulmonary conditions. Overall,
1 SD reduction in RVEF was robustly associated with adverse outcomes (HR: 2.64 [95%
CI: 2.18 to 3.20], p<0.001; heterogeneity: I2=65%, p=0.002). In studies reporting
HRs for RVEF and TAPSE, FAC, or FWLS in the same cohort, head-to-head comparison revealed
that RVEF showed significantly stronger association with adverse outcomes per SD reduction
versus the other three parameters (vs.1.54 [95% CI: 1.04 to 2.28], p=0.031; vs. FAC,
HR: 1.45 [95% CI: 1.15 to 1.81], p=0.001; vs. FWLS, HR: 1.44 [95% CI: 1.07 to 1.95],
p=0.018).Reduction in 3DE-derived RVEF shows stronger association with adverse clinical
outcomes than conventional RV functional indices, therefore, it might further refine
the risk stratification of patients with cardiopulmonary diseases.